- The trend backdrop is active with a 22-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
3176
TWO
Week ended 14 Aug 2026
Weekly Investor Report
Medigen Biotechnology Corp. · Healthcare · Biotechnology
Latest close
33.75 TWD
0.1%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 3.1% above the Trend Line and sits at 36.9% of its 52-week range. The latest completed week returned 0.1%, after a 0.6% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
34
out of 100
Latest Close
33.75 TWD
14 Aug 2026
1W Return
0.1%
latest completed week
4W Return
0.6%
short-term follow-through
12W Return
-9.4%
quarterly tape
Trend Breadth
59.6%
31 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 41.64% based on similar historical setup states.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.1%
Latest completed week; four-week move 0.6%.
Indicator stack
78/25
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.64%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 3.1% above the Trend Line and sits at 36.9% of its 52-week range. The latest completed week returned 0.1%, after a 0.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4912-week average 0.53
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.49Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.6% over four weeks, -9.4% over 12 weeks, and 8.9% over one year. The current trend has remained active for 22 consecutive weeks.
Performance by holding period
Active trend streak22 weeks
Active weeks in one year31
Trend breadth59.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.53Latest activity-pressure read.
Pressure change-191.7%Four-week change in activity pressure.
Leadership-23.88Latest relative-leadership reading.
RS change-7.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-22.6%Distance below the 52-week high.
13-week volatility7.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher13 of 2612 weeks finished lower.
Best week+10.9%Week of 22 May.
Worst week-12.2%Week of 29 May.
Latest week+0.1%Week of 14 Aug.
Shape of recent returns
Strong gains7
Modest gains6
Flat weeks1
Modest losses7
Sharp losses5
Recent vol7.3%13-week weekly-return volatility.
Base vol4.4%52-week weekly-return volatility.
Up/down split23/27Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -2.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank45 / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank32 / 96
Group average-2.7%
Trend breadth24.0%
Trend24.0%active weekly trend signals
MD39.6%positive activity pressure
RS6.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape35/100
Trend, activity pressure, participation, and risk combine to a 35/100 tape read.
Indicator analysis60/100Latest 12-week confirmation: trend 12/12, activity pressure 10/12, relative leadership 0/12.
Activity pressure 0.49; No reversal markers Next-Week ExpectancyNegative 41.64%Next-week expectancy is negative with a 41.64% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 33.75 TWD | 0.1% | 32.75 TWD | 35.57 TWD | -0.53 | -23.88 | 1.8M | On |
| 7 Aug 2026 | 33.70 TWD | 8.2% | 32.70 TWD | 35.55 TWD | -0.33 | -22.13 | 3.3M | On |
| 31 Jul 2026 | 31.15 TWD | -5.6% | 32.67 TWD | 35.54 TWD | 0.13 | -26.97 | 1.4M | On |
| 24 Jul 2026 | 33.00 TWD | -1.6% | 32.71 TWD | 35.56 TWD | 0.57 | -24.48 | 1.3M | On |
| 17 Jul 2026 | 33.55 TWD | -12.2% | 32.66 TWD | 35.56 TWD | 0.58 | -22.29 | 3.1M | On |
| 10 Jul 2026 | 38.20 TWD | 8.1% | 32.57 TWD | 35.55 TWD | 0.62 | -17.60 | 6.3M | On |
| 3 Jul 2026 | 35.35 TWD | 8.6% | 32.33 TWD | 35.52 TWD | 0.43 | -26.79 | 3.3M | On |
| 26 Jun 2026 | 32.55 TWD | -3.0% | 32.16 TWD | 35.51 TWD | 0.35 | -30.03 | 2.0M | On |
| 19 Jun 2026 | 33.55 TWD | 0.3% | 32.07 TWD | 35.51 TWD | 0.57 | -31.63 | 1.9M | On |
| 12 Jun 2026 | 33.45 TWD | 4.4% | 31.95 TWD | 35.52 TWD | 0.88 | -29.16 | 4.5M | On |
| 5 Jun 2026 | 32.05 TWD | -2.0% | 31.87 TWD | 35.51 TWD | 0.93 | -34.28 | 4.0M | On |
| 29 May 2026 | 32.70 TWD | -12.2% | 31.78 TWD | 35.52 TWD | 0.90 | -33.32 | 4.7M | On |
| 22 May 2026 | 37.25 TWD | 10.9% | 31.69 TWD | 35.52 TWD | 0.88 | -20.62 | 11.8M | On |
| 15 May 2026 | 33.60 TWD | 1.7% | 31.44 TWD | 35.49 TWD | 0.48 | -27.22 | 3.0M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.